Autologous CD19-CD20-NKG2D-nsBicephali CAR-T for Relapsed/Refractory Central Nervous System Lymphoma

Clinical trial NCT07555561 · SUSPENDED

Trial details

NCT number: NCT07555561
Sponsor: Beijing Boren Hospital
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory Central Nervous System Lymphoma Relapsed/Refractory Primary Central Nervous System Lymphoma Relapsed/Refractory Secondary Central Nervous System Lymphoma

Start date: 2026-09-01
Primary completion: 2027-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.